메뉴 건너뛰기




Volumn 94, Issue 19, 1997, Pages 10018-10023

A vaccine for HIV type 1: The antibody perspective

Author keywords

Gp120; Gp41; HIV envelope; Neutralizing antibodies; Passive immunization

Indexed keywords

GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEUTRALIZING ANTIBODY; VIRUS ENVELOPE PROTEIN;

EID: 0030885594     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.94.19.10018     Document Type: Review
Times cited : (203)

References (76)
  • 13
    • 0005000433 scopus 로고
    • Moore, J. P. & Ho, D. D. (1995) AIDS 9, Suppl. A, S117-S136.
    • (1995) AIDS , vol.9 , Issue.SUPPL. A
    • Moore, J.P.1    Ho, D.D.2
  • 14
    • 0030340537 scopus 로고    scopus 로고
    • Kent, K. A. & Robinson, J. (1996) AIDS 10, Suppl. A, S107-S114.
    • (1996) AIDS , vol.10 , Issue.SUPPL. A
    • Kent, K.A.1    Robinson, J.2
  • 53
    • 1842373580 scopus 로고
    • Desrosiers, R. C. (1995) AIDS 9, Suppl. A, S137-S141.
    • (1995) AIDS , vol.9 , Issue.SUPPL. A
    • Desrosiers, R.C.1
  • 57
    • 0027935311 scopus 로고
    • Levy, J., Youvan, T., Lee, M. L. & Passive Hyperimmune Therapy Study Group (1994) Blood 84, 2130-2135.
    • (1994) Blood , vol.84 , pp. 2130-2135
    • Levy, J.1    Youvan, T.2    Lee, M.L.3
  • 68
    • 0030571189 scopus 로고    scopus 로고
    • Haynes, B. F. (1996) Lancet 348, 933-937.
    • (1996) Lancet , vol.348 , pp. 933-937
    • Haynes, B.F.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.